Your browser doesn't support javascript.
loading
Pre-activated human mesenchymal stromal cells in combination with doxorubicin synergistically enhance tumor-suppressive activity in mice.
Yoon, Nara; Park, Min Sung; Peltier, Grantham C; Lee, Ryang Hwa.
Affiliation
  • Yoon N; Institute for Regenerative Medicine, College of Medicine, Texas A&M University Health Science Center, Temple, Texas, USA.
  • Park MS; Institute for Regenerative Medicine, College of Medicine, Texas A&M University Health Science Center, Temple, Texas, USA.
  • Peltier GC; Institute for Regenerative Medicine, College of Medicine, Texas A&M University Health Science Center, Temple, Texas, USA.
  • Lee RH; Institute for Regenerative Medicine, College of Medicine, Texas A&M University Health Science Center, Temple, Texas, USA. Electronic address: rlee@medicine.tamhsc.edu.
Cytotherapy ; 17(10): 1332-41, 2015 Oct.
Article in En | MEDLINE | ID: mdl-26227206
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Doxorubicin / Apoptosis / Mesenchymal Stem Cell Transplantation / TNF-Related Apoptosis-Inducing Ligand / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Cytotherapy Journal subject: TERAPEUTICA Year: 2015 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Doxorubicin / Apoptosis / Mesenchymal Stem Cell Transplantation / TNF-Related Apoptosis-Inducing Ligand / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Cytotherapy Journal subject: TERAPEUTICA Year: 2015 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido